-
AI-assisted approach identifies IRS4 as a promising drug target in multiple solid tumors
04/29/2026
Learn a new strategy scientists used to find a low-toxicity, cross-tumor dependency as a proof of principle to find safer targets for cancer drug discovery.
-
Antisense oligonucleotide strategy reverses HNRNPH2-related neurodevelopmental disorder
04/22/2026
See how an antisense oligonucleotide reverses ultrarare X-linked genetic condition HNRNPH2-related neurodevelopmental disorder in preclinical study
-
Enhancer provides a potential target for “undruggable” MYC in pediatric medulloblastoma
04/22/2026
Learn how St. Jude researchers identified a tumor-specific enhancer driving MYC in pediatric medulloblastoma, revealing a promising new therapeutic target.
-
Damon Runyon Cancer Research Foundation and St. Jude Children’s Research Hospital award 2026 fellowships
04/21/2026
Early-career investigators studying pediatric cancers, including Ewing sarcoma, leukemia and kidney cancer, were selected this year.
-
‘Fingerprints’ of childhood cancer treatment provide clues that may help mitigate second cancers
04/19/2026
Learn how new research of the traces life-saving pediatric cancer treatments leave in DNA could help improve the detection and prevention of second neoplasms.
-
3D tumor organoids give brain tumor researchers new scientific opportunities
04/15/2026
Learn about brain tumor organoids developed by St. Jude scientists that preserve tumor diversity, enabling faster research and better access to research models
-
First continent-wide map of dominant avian influenza strain explains its spread
04/15/2026
Find out how mapping the spread of an avian influenza strain through birds across North America helped scientists understand its human-to-human spread risk.
-
AACR annual meeting highlights St. Jude research, honors Comprehensive Cancer Center director
04/14/2026
Several St. Jude researchers featured at AACR 2026
-
Study identifies PHIP as a novel dependency in cancers driven by SWI/SNF mutations
04/07/2026
Discover research from St. Jude identifying PHIP as a novel dependency in cancers that have mutations in SWI/SNF
-
Data platform unifies blood cancer ‘omics’ and clinical data to accelerate discovery
04/06/2026
Take a first look at the American Society of Hematology HematOmics Program (ASHOP) platform & its promise to move hematological malignancy research forward.
Explore more research news
More Research News
-
Scientific Report
St. Jude Researchers, backed by extraordinary resources and support teams, are focused on making big discoveries.
Clinical Trials Alerts
Our e-newsletter for clinicians offers updates on St. Jude open clinical trials and research news.
Follow Us on Social Media
Connect with @stjuderesearch to keep up with our latest science and medical news. More about St. Jude social media.
Peer-Reviewed Publications
Browse all scientific publications by St. Jude investigators.
-
Clinical & Research Innovation
At St. Jude, we dream big, and build our research programs to match. Explore just a few of the pioneering initiatives that make St. Jude different.
-
Research and Hospital Careers
Explore research and hospital careers at St. Jude. We offer rewarding job opportunities in scientific research, clinical care and business operations.
-
St. Jude Global
St. Jude Global is striving to create a network of programs and institutions to treat childhood diseases. Learn more about our newest initiatives.
-
Education and Training
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
-
Pediatric Cancer Genome Project
Launched in 2010, the Pediatric Cancer Genome Project became the world’s most ambitious effort to discover the origins of pediatric cancer. Learn about its discoveries.